

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glycosphingolipid catabolic process (GO:0046479) | 5.02586809 |
| 2 | negative regulation of interleukin-12 production (GO:0032695) | 4.98319026 |
| 3 | oligosaccharide catabolic process (GO:0009313) | 4.94611927 |
| 4 | response to peptidoglycan (GO:0032494) | 4.68063550 |
| 5 | regulation of mononuclear cell migration (GO:0071675) | 4.58455947 |
| 6 | glycolipid catabolic process (GO:0019377) | 4.52601749 |
| 7 | neutrophil activation involved in immune response (GO:0002283) | 4.45377092 |
| 8 | amino sugar catabolic process (GO:0046348) | 4.33530137 |
| 9 | ceramide catabolic process (GO:0046514) | 4.04044935 |
| 10 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.99988948 |
| 11 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.96964611 |
| 12 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.91292628 |
| 13 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.81011202 |
| 14 | immunoglobulin mediated immune response (GO:0016064) | 3.80950012 |
| 15 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.75066901 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 3.70856693 |
| 17 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.70146586 |
| 18 | membrane lipid catabolic process (GO:0046466) | 3.57383352 |
| 19 | sphingolipid catabolic process (GO:0030149) | 3.46205371 |
| 20 | regulation of podosome assembly (GO:0071801) | 3.43276857 |
| 21 | regulation of cholesterol storage (GO:0010885) | 3.40894329 |
| 22 | T-helper 1 type immune response (GO:0042088) | 3.40057963 |
| 23 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.38765100 |
| 24 | response to thyroid hormone (GO:0097066) | 3.36953050 |
| 25 | myeloid dendritic cell differentiation (GO:0043011) | 3.35859518 |
| 26 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.34959193 |
| 27 | monocyte chemotaxis (GO:0002548) | 3.34370951 |
| 28 | regulation of chemokine biosynthetic process (GO:0045073) | 3.31879684 |
| 29 | regulation of vitamin metabolic process (GO:0030656) | 3.27376131 |
| 30 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.25798756 |
| 31 | N-acetylneuraminate metabolic process (GO:0006054) | 3.25582017 |
| 32 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.19901658 |
| 33 | granulocyte activation (GO:0036230) | 3.18818371 |
| 34 | NIK/NF-kappaB signaling (GO:0038061) | 3.16257379 |
| 35 | regulation of macrophage chemotaxis (GO:0010758) | 3.12856703 |
| 36 | positive regulation by symbiont of host defense response (GO:0052509) | 3.10892081 |
| 37 | modulation by symbiont of host defense response (GO:0052031) | 3.10892081 |
| 38 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.10892081 |
| 39 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.10892081 |
| 40 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.10892081 |
| 41 | modulation by symbiont of host immune response (GO:0052553) | 3.10892081 |
| 42 | adhesion of symbiont to host cell (GO:0044650) | 3.10630302 |
| 43 | virion attachment to host cell (GO:0019062) | 3.10630302 |
| 44 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.09883435 |
| 45 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.05632334 |
| 46 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.05404492 |
| 47 | regulation of mast cell degranulation (GO:0043304) | 3.05314537 |
| 48 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.02176833 |
| 49 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.01777107 |
| 50 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.99275454 |
| 51 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.99173281 |
| 52 | regulation of interferon-alpha production (GO:0032647) | 2.98619873 |
| 53 | detection of molecule of bacterial origin (GO:0032490) | 2.98021389 |
| 54 | myeloid dendritic cell activation (GO:0001773) | 2.97389304 |
| 55 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.95619361 |
| 56 | eosinophil chemotaxis (GO:0048245) | 2.94085369 |
| 57 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.91422002 |
| 58 | positive regulation of heat generation (GO:0031652) | 2.91087595 |
| 59 | positive regulation of antigen processing and presentation (GO:0002579) | 2.87877110 |
| 60 | regulation of chronic inflammatory response (GO:0002676) | 2.86301617 |
| 61 | phagosome maturation (GO:0090382) | 2.85446451 |
| 62 | positive regulation of leukocyte degranulation (GO:0043302) | 2.85058149 |
| 63 | keratan sulfate catabolic process (GO:0042340) | 2.85004539 |
| 64 | dendritic cell differentiation (GO:0097028) | 2.84471506 |
| 65 | cellular response to type I interferon (GO:0071357) | 2.84347099 |
| 66 | type I interferon signaling pathway (GO:0060337) | 2.84347099 |
| 67 | positive regulation of mast cell degranulation (GO:0043306) | 2.81110731 |
| 68 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.81110731 |
| 69 | B cell mediated immunity (GO:0019724) | 2.80611565 |
| 70 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.79724995 |
| 71 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.79134571 |
| 72 | response to type I interferon (GO:0034340) | 2.78430232 |
| 73 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.77401740 |
| 74 | myeloid cell activation involved in immune response (GO:0002275) | 2.76947073 |
| 75 | regulation of monocyte chemotaxis (GO:0090025) | 2.76333938 |
| 76 | regulation of antigen processing and presentation (GO:0002577) | 2.76266884 |
| 77 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.76102623 |
| 78 | response to protozoan (GO:0001562) | 2.75940052 |
| 79 | cellular response to lipopolysaccharide (GO:0071222) | 2.75370776 |
| 80 | cellular response to arsenic-containing substance (GO:0071243) | 2.73593599 |
| 81 | adhesion of symbiont to host (GO:0044406) | 2.73348138 |
| 82 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.72076368 |
| 83 | negative regulation of lipid storage (GO:0010888) | 2.71963045 |
| 84 | regulation of fever generation (GO:0031620) | 2.70089895 |
| 85 | positive regulation of mast cell activation (GO:0033005) | 2.70065604 |
| 86 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.69804262 |
| 87 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.69751043 |
| 88 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.69244186 |
| 89 | defense response to protozoan (GO:0042832) | 2.68611481 |
| 90 | regulation of superoxide anion generation (GO:0032928) | 2.68399865 |
| 91 | cellular response to molecule of bacterial origin (GO:0071219) | 2.68287734 |
| 92 | eosinophil migration (GO:0072677) | 2.66964193 |
| 93 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.66775240 |
| 94 | regulation of leukocyte degranulation (GO:0043300) | 2.66358412 |
| 95 | positive regulation of interleukin-6 production (GO:0032755) | 2.66215033 |
| 96 | low-density lipoprotein particle clearance (GO:0034383) | 2.66170347 |
| 97 | macrophage activation (GO:0042116) | 2.65878729 |
| 98 | pinocytosis (GO:0006907) | 2.65488152 |
| 99 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.63419806 |
| 100 | regulation of interleukin-12 production (GO:0032655) | 2.61281767 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.41107733 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.20780125 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.45567411 |
| 4 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 4.30895148 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.81533568 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.48214453 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.32532828 |
| 8 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.20490755 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.15907919 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.73624420 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.71249706 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.66862047 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.63071369 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.35348960 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.17833732 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.14928031 |
| 17 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.12343000 |
| 18 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.07728152 |
| 19 | * VDR_24787735_ChIP-Seq_THP-1_Human | 2.02335749 |
| 20 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.00541345 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.97633056 |
| 22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.96099125 |
| 23 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.89696880 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.84382386 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.81666940 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.81150974 |
| 27 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78227934 |
| 28 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.77201989 |
| 29 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.76830917 |
| 30 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74505418 |
| 31 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.74372895 |
| 32 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.72203692 |
| 33 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.67223939 |
| 34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.64438465 |
| 35 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.64345016 |
| 36 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60765130 |
| 37 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.55211856 |
| 38 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.53998038 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.53241860 |
| 40 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.50765778 |
| 41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.49205359 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.47434761 |
| 43 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.47113078 |
| 44 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.46504260 |
| 45 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.46451196 |
| 46 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.45769996 |
| 47 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.44360844 |
| 48 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.42451756 |
| 49 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38904458 |
| 50 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.37354047 |
| 51 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.36218556 |
| 52 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.35920148 |
| 53 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.35232971 |
| 54 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34866230 |
| 55 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33567675 |
| 56 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32036303 |
| 57 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31778207 |
| 58 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.31638916 |
| 59 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31517099 |
| 60 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.29431049 |
| 61 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29242081 |
| 62 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.26473616 |
| 63 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.24782161 |
| 64 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.24485735 |
| 65 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.22483166 |
| 66 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.21840065 |
| 67 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17503145 |
| 68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.16991651 |
| 69 | * MAF_26560356_Chip-Seq_TH1_Human | 1.16725020 |
| 70 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15643985 |
| 71 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.10628383 |
| 72 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10058086 |
| 73 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08652361 |
| 74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06847936 |
| 75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05208905 |
| 76 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04254878 |
| 77 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00798845 |
| 78 | GATA1_22025678_ChIP-Seq_K562_Human | 0.99237198 |
| 79 | MYB_26560356_Chip-Seq_TH2_Human | 0.99198422 |
| 80 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.97332325 |
| 81 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.96272078 |
| 82 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.95723757 |
| 83 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.95033980 |
| 84 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94896151 |
| 85 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.93601862 |
| 86 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93250315 |
| 87 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.90764220 |
| 88 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.89424619 |
| 89 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.88091658 |
| 90 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.86682022 |
| 91 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.86128397 |
| 92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86017777 |
| 93 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.84662275 |
| 94 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83760372 |
| 95 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82969194 |
| 96 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82290200 |
| 97 | * MAF_26560356_Chip-Seq_TH2_Human | 0.82069761 |
| 98 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.81351978 |
| 99 | MYB_26560356_Chip-Seq_TH1_Human | 0.80322668 |
| 100 | GATA3_26560356_Chip-Seq_TH2_Human | 0.79257687 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.71082615 |
| 2 | MP0003303_peritoneal_inflammation | 4.21572376 |
| 3 | MP0009840_abnormal_foam_cell | 3.83689530 |
| 4 | MP0006082_CNS_inflammation | 3.73811913 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.59034799 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.17492813 |
| 7 | MP0003172_abnormal_lysosome_physiology | 3.10135834 |
| 8 | MP0003436_decreased_susceptibility_to | 2.93924493 |
| 9 | MP0003724_increased_susceptibility_to | 2.91032283 |
| 10 | MP0009785_altered_susceptibility_to | 2.83265237 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.63507395 |
| 12 | MP0002419_abnormal_innate_immunity | 2.59406969 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.56887286 |
| 14 | MP0000604_amyloidosis | 2.48537244 |
| 15 | MP0000343_altered_response_to | 2.32513845 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 2.31827008 |
| 17 | MP0004510_myositis | 2.27507630 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.26058544 |
| 19 | MP0005387_immune_system_phenotype | 2.25388313 |
| 20 | MP0001790_abnormal_immune_system | 2.25388313 |
| 21 | MP0005671_abnormal_response_to | 2.24535735 |
| 22 | MP0005025_abnormal_response_to | 2.22362222 |
| 23 | MP0003075_altered_response_to | 2.20222900 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.12293270 |
| 25 | MP0009764_decreased_sensitivity_to | 2.03032038 |
| 26 | MP0001533_abnormal_skeleton_physiology | 1.93579653 |
| 27 | MP0002254_reproductive_system_inflammat | 1.93095623 |
| 28 | MP0002452_abnormal_antigen_presenting | 1.92125797 |
| 29 | MP0005451_abnormal_body_composition | 1.87031496 |
| 30 | MP0006054_spinal_hemorrhage | 1.86685332 |
| 31 | MP0001853_heart_inflammation | 1.86206669 |
| 32 | MP0002723_abnormal_immune_serum | 1.80899161 |
| 33 | MP0000685_abnormal_immune_system | 1.74273205 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.67049243 |
| 35 | MP0001800_abnormal_humoral_immune | 1.63323746 |
| 36 | MP0003690_abnormal_glial_cell | 1.62343240 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.62036356 |
| 38 | MP0005397_hematopoietic_system_phenotyp | 1.62036356 |
| 39 | MP0008469_abnormal_protein_level | 1.61496396 |
| 40 | MP0009278_abnormal_bone_marrow | 1.60619706 |
| 41 | MP0002998_abnormal_bone_remodeling | 1.60250363 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.57465102 |
| 43 | MP0002420_abnormal_adaptive_immunity | 1.51976061 |
| 44 | MP0008004_abnormal_stomach_pH | 1.51834443 |
| 45 | MP0001819_abnormal_immune_cell | 1.51772529 |
| 46 | MP0002405_respiratory_system_inflammati | 1.51114704 |
| 47 | MP0005310_abnormal_salivary_gland | 1.49768568 |
| 48 | MP0005167_abnormal_blood-brain_barrier | 1.45047806 |
| 49 | MP0003195_calcinosis | 1.42806470 |
| 50 | MP0003448_altered_tumor_morphology | 1.42305160 |
| 51 | MP0005365_abnormal_bile_salt | 1.40969702 |
| 52 | MP0004947_skin_inflammation | 1.39160076 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.31957630 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.31875717 |
| 55 | MP0003656_abnormal_erythrocyte_physiolo | 1.28522022 |
| 56 | MP0003453_abnormal_keratinocyte_physiol | 1.27068812 |
| 57 | MP0000858_altered_metastatic_potential | 1.26895453 |
| 58 | MP0005166_decreased_susceptibility_to | 1.26862191 |
| 59 | MP0003329_amyloid_beta_deposits | 1.18951237 |
| 60 | MP0003186_abnormal_redox_activity | 1.15083408 |
| 61 | MP0005164_abnormal_response_to | 1.14174178 |
| 62 | MP0001542_abnormal_bone_strength | 1.09819420 |
| 63 | MP0000920_abnormal_myelination | 1.07780619 |
| 64 | MP0008260_abnormal_autophagy | 1.07297586 |
| 65 | MP0002138_abnormal_hepatobiliary_system | 1.04650836 |
| 66 | MP0000716_abnormal_immune_system | 1.01331540 |
| 67 | MP0005165_increased_susceptibility_to | 0.98739206 |
| 68 | MP0009763_increased_sensitivity_to | 0.95275500 |
| 69 | MP0004883_abnormal_blood_vessel | 0.88158701 |
| 70 | MP0005390_skeleton_phenotype | 0.87913331 |
| 71 | MP0002090_abnormal_vision | 0.85996176 |
| 72 | MP0002332_abnormal_exercise_endurance | 0.85365719 |
| 73 | MP0000689_abnormal_spleen_morphology | 0.81370008 |
| 74 | MP0003828_pulmonary_edema | 0.81175502 |
| 75 | MP0005257_abnormal_intraocular_pressure | 0.79910606 |
| 76 | MP0002429_abnormal_blood_cell | 0.78495511 |
| 77 | MP0003183_abnormal_peptide_metabolism | 0.76018091 |
| 78 | MP0003795_abnormal_bone_structure | 0.75793733 |
| 79 | MP0002398_abnormal_bone_marrow | 0.74920655 |
| 80 | MP0005319_abnormal_enzyme/_coenzyme | 0.73811217 |
| 81 | MP0005023_abnormal_wound_healing | 0.73700001 |
| 82 | MP0000609_abnormal_liver_physiology | 0.72830189 |
| 83 | MP0005647_abnormal_sex_gland | 0.72129957 |
| 84 | MP0004019_abnormal_vitamin_homeostasis | 0.71248357 |
| 85 | MP0000371_diluted_coat_color | 0.69972211 |
| 86 | MP0001663_abnormal_digestive_system | 0.69247536 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 0.67822459 |
| 88 | MP0010307_abnormal_tumor_latency | 0.67629663 |
| 89 | MP0002933_joint_inflammation | 0.67079758 |
| 90 | MP0003279_aneurysm | 0.65711200 |
| 91 | MP0002722_abnormal_immune_system | 0.65049109 |
| 92 | MP0003634_abnormal_glial_cell | 0.63988887 |
| 93 | MP0008874_decreased_physiological_sensi | 0.63191978 |
| 94 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.62936293 |
| 95 | MP0001764_abnormal_homeostasis | 0.60506543 |
| 96 | MP0003091_abnormal_cell_migration | 0.60434815 |
| 97 | MP0000249_abnormal_blood_vessel | 0.58233860 |
| 98 | MP0002877_abnormal_melanocyte_morpholog | 0.58088948 |
| 99 | MP0002277_abnormal_respiratory_mucosa | 0.57116464 |
| 100 | MP0002837_dystrophic_cardiac_calcinosis | 0.56168762 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 8.83818663 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 8.83818663 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 8.83818663 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 6.22047327 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 5.57453269 |
| 6 | Increased cerebral lipofuscin (HP:0011813) | 5.57031250 |
| 7 | Dysostosis multiplex (HP:0000943) | 5.05786056 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.96794102 |
| 9 | Loss of speech (HP:0002371) | 4.93414615 |
| 10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.55236236 |
| 11 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.00551508 |
| 12 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.00551508 |
| 13 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.00551508 |
| 14 | Mucopolysacchariduria (HP:0008155) | 3.77760639 |
| 15 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.77760639 |
| 16 | Recurrent abscess formation (HP:0002722) | 3.76646740 |
| 17 | Recurrent bacterial skin infections (HP:0005406) | 3.75540315 |
| 18 | * Disinhibition (HP:0000734) | 3.61556611 |
| 19 | Glomerulonephritis (HP:0000099) | 3.56689831 |
| 20 | Neurofibrillary tangles (HP:0002185) | 3.47440232 |
| 21 | Axonal loss (HP:0003447) | 3.46665062 |
| 22 | Eczematoid dermatitis (HP:0000976) | 3.45818594 |
| 23 | Autoimmune thrombocytopenia (HP:0001973) | 3.35328468 |
| 24 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.26360173 |
| 25 | Stomatitis (HP:0010280) | 3.21154991 |
| 26 | Orchitis (HP:0100796) | 3.16999771 |
| 27 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.14301947 |
| 28 | Purpura (HP:0000979) | 3.05938706 |
| 29 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.00171688 |
| 30 | Optic neuritis (HP:0100653) | 2.98792254 |
| 31 | Retrobulbar optic neuritis (HP:0100654) | 2.98792254 |
| 32 | Diminished motivation (HP:0000745) | 2.96681214 |
| 33 | Apathy (HP:0000741) | 2.96631516 |
| 34 | Myositis (HP:0100614) | 2.96419750 |
| 35 | Mediastinal lymphadenopathy (HP:0100721) | 2.96366127 |
| 36 | Myocardial infarction (HP:0001658) | 2.95883133 |
| 37 | Complement deficiency (HP:0004431) | 2.95799138 |
| 38 | Progressive neurologic deterioration (HP:0002344) | 2.87091972 |
| 39 | Agnosia (HP:0010524) | 2.83412265 |
| 40 | * Mutism (HP:0002300) | 2.73874483 |
| 41 | Hepatosplenomegaly (HP:0001433) | 2.73199299 |
| 42 | Petechiae (HP:0000967) | 2.71191158 |
| 43 | Upper motor neuron abnormality (HP:0002127) | 2.68206700 |
| 44 | Prolonged neonatal jaundice (HP:0006579) | 2.58847103 |
| 45 | Neuronal loss in central nervous system (HP:0002529) | 2.57019426 |
| 46 | Metaphyseal irregularity (HP:0003025) | 2.54274999 |
| 47 | Amyloidosis (HP:0011034) | 2.52593776 |
| 48 | Obstructive lung disease (HP:0006536) | 2.51952769 |
| 49 | Chronic obstructive pulmonary disease (HP:0006510) | 2.51952769 |
| 50 | Hematochezia (HP:0002573) | 2.43796520 |
| 51 | Retinal atrophy (HP:0001105) | 2.43624797 |
| 52 | Abnormality of complement system (HP:0005339) | 2.37394554 |
| 53 | Cerebral inclusion bodies (HP:0100314) | 2.36625393 |
| 54 | Nausea (HP:0002018) | 2.34063673 |
| 55 | Personality changes (HP:0000751) | 2.33136366 |
| 56 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.30374332 |
| 57 | Pulmonary infiltrates (HP:0002113) | 2.24130014 |
| 58 | Vertebral compression fractures (HP:0002953) | 2.19320323 |
| 59 | Polyneuropathy (HP:0001271) | 2.13693466 |
| 60 | Cardiomegaly (HP:0001640) | 2.10392359 |
| 61 | Increased CSF protein (HP:0002922) | 2.06350564 |
| 62 | Recurrent skin infections (HP:0001581) | 2.06017225 |
| 63 | Basal ganglia calcification (HP:0002135) | 2.05651690 |
| 64 | Pathologic fracture (HP:0002756) | 2.03341794 |
| 65 | * Dementia (HP:0000726) | 2.01070366 |
| 66 | * Increased serum ferritin (HP:0003281) | 1.99389333 |
| 67 | Malnutrition (HP:0004395) | 1.95776100 |
| 68 | Peripheral demyelination (HP:0011096) | 1.94210930 |
| 69 | Xanthomatosis (HP:0000991) | 1.93423457 |
| 70 | Keratoconjunctivitis sicca (HP:0001097) | 1.93405442 |
| 71 | Supranuclear gaze palsy (HP:0000605) | 1.89288976 |
| 72 | Bone pain (HP:0002653) | 1.88476325 |
| 73 | Asymmetric septal hypertrophy (HP:0001670) | 1.88239227 |
| 74 | Conjunctival telangiectasia (HP:0000524) | 1.88067132 |
| 75 | Increased IgM level (HP:0003496) | 1.87911886 |
| 76 | Gingivitis (HP:0000230) | 1.86946456 |
| 77 | Interstitial pulmonary disease (HP:0006530) | 1.86912783 |
| 78 | Beaking of vertebral bodies (HP:0004568) | 1.86001362 |
| 79 | Global brain atrophy (HP:0002283) | 1.84584260 |
| 80 | Hemoptysis (HP:0002105) | 1.84163062 |
| 81 | Spontaneous hematomas (HP:0007420) | 1.84120572 |
| 82 | Nephritis (HP:0000123) | 1.80800596 |
| 83 | Abnormality of the periventricular white matter (HP:0002518) | 1.80272817 |
| 84 | J-shaped sella turcica (HP:0002680) | 1.79437653 |
| 85 | Multiple enchondromatosis (HP:0005701) | 1.78434097 |
| 86 | Vasculitis (HP:0002633) | 1.78365237 |
| 87 | Memory impairment (HP:0002354) | 1.77068654 |
| 88 | Keratoconjunctivitis (HP:0001096) | 1.75158487 |
| 89 | Thoracic kyphosis (HP:0002942) | 1.72085410 |
| 90 | Recurrent fungal infections (HP:0002841) | 1.71630063 |
| 91 | * Inappropriate behavior (HP:0000719) | 1.71077117 |
| 92 | Poor head control (HP:0002421) | 1.70648709 |
| 93 | Urticaria (HP:0001025) | 1.70037163 |
| 94 | Generalized aminoaciduria (HP:0002909) | 1.68045211 |
| 95 | * Nuclear cataract (HP:0100018) | 1.67580964 |
| 96 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.66850700 |
| 97 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.66726596 |
| 98 | Tetraparesis (HP:0002273) | 1.66204593 |
| 99 | Splenomegaly (HP:0001744) | 1.65878810 |
| 100 | Albinism (HP:0001022) | 1.65226678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 4.68340484 |
| 2 | NME2 | 4.38482145 |
| 3 | GRK7 | 3.55098417 |
| 4 | BLK | 2.87163578 |
| 5 | TGFBR2 | 2.75932381 |
| 6 | MAP3K14 | 2.66290458 |
| 7 | DDR2 | 2.66117012 |
| 8 | TAOK2 | 2.66108685 |
| 9 | TBK1 | 2.64489764 |
| 10 | MAP3K11 | 2.42890875 |
| 11 | TYK2 | 2.38885432 |
| 12 | ERN1 | 2.28615914 |
| 13 | RIPK4 | 2.28160155 |
| 14 | MAP3K3 | 2.18183357 |
| 15 | MATK | 2.16413219 |
| 16 | PIM2 | 2.15714424 |
| 17 | ACVR1B | 2.05951935 |
| 18 | FGR | 2.03690679 |
| 19 | IKBKB | 1.94383478 |
| 20 | MAP2K3 | 1.83536029 |
| 21 | ABL2 | 1.82387354 |
| 22 | IRAK4 | 1.82248069 |
| 23 | CSK | 1.77172205 |
| 24 | TAOK1 | 1.71511611 |
| 25 | MOS | 1.65777361 |
| 26 | MAP4K1 | 1.64592458 |
| 27 | ADRBK2 | 1.60847982 |
| 28 | RIPK1 | 1.47380105 |
| 29 | TESK1 | 1.44420831 |
| 30 | PRPF4B | 1.40245977 |
| 31 | IKBKE | 1.38995578 |
| 32 | SIK3 | 1.36252624 |
| 33 | ZAP70 | 1.30624156 |
| 34 | JAK3 | 1.28585011 |
| 35 | BMPR2 | 1.25366411 |
| 36 | TESK2 | 1.22850777 |
| 37 | CDC42BPA | 1.21254691 |
| 38 | TXK | 1.20104429 |
| 39 | CSF1R | 1.15628361 |
| 40 | MAP3K1 | 1.13521967 |
| 41 | MAP3K13 | 1.11403528 |
| 42 | LYN | 1.03691939 |
| 43 | PDK2 | 1.03050898 |
| 44 | MAP3K5 | 1.00353661 |
| 45 | CAMKK2 | 0.99572731 |
| 46 | LIMK1 | 0.92834580 |
| 47 | SYK | 0.92326059 |
| 48 | ARAF | 0.92211695 |
| 49 | CHUK | 0.91375045 |
| 50 | PAK4 | 0.86851493 |
| 51 | MAP2K6 | 0.85487488 |
| 52 | MARK3 | 0.81872019 |
| 53 | JAK1 | 0.80612998 |
| 54 | MAP3K12 | 0.78096814 |
| 55 | IRAK2 | 0.75634779 |
| 56 | JAK2 | 0.74419272 |
| 57 | FES | 0.73183594 |
| 58 | KIT | 0.71435238 |
| 59 | LCK | 0.70322999 |
| 60 | STK10 | 0.69663372 |
| 61 | PBK | 0.65892758 |
| 62 | CAMK1D | 0.63544022 |
| 63 | HCK | 0.63213298 |
| 64 | CLK1 | 0.61203327 |
| 65 | DAPK2 | 0.54618226 |
| 66 | IRAK1 | 0.54156901 |
| 67 | NEK9 | 0.52336736 |
| 68 | DAPK3 | 0.51934304 |
| 69 | BMX | 0.49954147 |
| 70 | BCKDK | 0.49196175 |
| 71 | TNK2 | 0.49106609 |
| 72 | BTK | 0.47463986 |
| 73 | TAOK3 | 0.45988325 |
| 74 | CDK6 | 0.45974334 |
| 75 | PIM1 | 0.45170923 |
| 76 | PRKG2 | 0.45090747 |
| 77 | TGFBR1 | 0.44521416 |
| 78 | ABL1 | 0.44224847 |
| 79 | PDPK1 | 0.42197504 |
| 80 | PDGFRA | 0.36447727 |
| 81 | MAPK4 | 0.36033207 |
| 82 | PDK1 | 0.33067516 |
| 83 | PRKCD | 0.32241849 |
| 84 | MAP3K8 | 0.31636311 |
| 85 | MAPKAPK2 | 0.31426279 |
| 86 | INSR | 0.27559541 |
| 87 | MST4 | 0.26402481 |
| 88 | ERBB4 | 0.25777479 |
| 89 | PAK1 | 0.25658877 |
| 90 | RPS6KL1 | 0.24924900 |
| 91 | RPS6KC1 | 0.24924900 |
| 92 | EGFR | 0.24416376 |
| 93 | GSK3A | 0.22614806 |
| 94 | KSR1 | 0.20906846 |
| 95 | LATS2 | 0.20214438 |
| 96 | MYLK | 0.20095606 |
| 97 | TYRO3 | 0.19543717 |
| 98 | FYN | 0.17479015 |
| 99 | ITK | 0.17079812 |
| 100 | KDR | 0.16482865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.54907274 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 3.83424540 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.28510094 |
| 4 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 3.04292873 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.88265508 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.59044950 |
| 7 | Asthma_Homo sapiens_hsa05310 | 2.53593876 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.43759848 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.36171437 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.35872293 |
| 11 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.12002433 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 2.10954941 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 2.09481456 |
| 14 | Malaria_Homo sapiens_hsa05144 | 2.09312748 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.04796766 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.95041173 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.93899855 |
| 18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.92234046 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 1.87650577 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.86415773 |
| 21 | Phagosome_Homo sapiens_hsa04145 | 1.83883761 |
| 22 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.79964202 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.75387686 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.69385492 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.68751465 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.66273730 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.65102346 |
| 28 | Salmonella infection_Homo sapiens_hsa05132 | 1.59558203 |
| 29 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.49653515 |
| 30 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.47374093 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.44267908 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.38963807 |
| 33 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.31962513 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.31757711 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.31265772 |
| 36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.29476697 |
| 37 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.27067442 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.21785670 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.20106955 |
| 40 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.18751355 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.17541419 |
| 42 | Prion diseases_Homo sapiens_hsa05020 | 1.17323314 |
| 43 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.14718217 |
| 44 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.13206939 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06105169 |
| 46 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.03240321 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 0.99732088 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 0.96137225 |
| 49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.90478320 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.90184113 |
| 51 | Galactose metabolism_Homo sapiens_hsa00052 | 0.90153320 |
| 52 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.80788279 |
| 53 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.79250687 |
| 54 | Measles_Homo sapiens_hsa05162 | 0.78995854 |
| 55 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.77200425 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 0.75072836 |
| 57 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.72607118 |
| 58 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.72043966 |
| 59 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.71928732 |
| 60 | Apoptosis_Homo sapiens_hsa04210 | 0.69896836 |
| 61 | Amoebiasis_Homo sapiens_hsa05146 | 0.67667654 |
| 62 | Bladder cancer_Homo sapiens_hsa05219 | 0.62897943 |
| 63 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.61788029 |
| 64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.60612061 |
| 65 | Hepatitis B_Homo sapiens_hsa05161 | 0.57580620 |
| 66 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51536416 |
| 67 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.48504407 |
| 68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48056217 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46242606 |
| 70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.45929965 |
| 71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.44909422 |
| 72 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.44417758 |
| 73 | * Mineral absorption_Homo sapiens_hsa04978 | 0.41542277 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41485509 |
| 75 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.41435467 |
| 76 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.39637988 |
| 77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.38891810 |
| 78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37406181 |
| 79 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.35443045 |
| 80 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.32574640 |
| 81 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.31429852 |
| 82 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.30719094 |
| 83 | Endocytosis_Homo sapiens_hsa04144 | 0.30103321 |
| 84 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.28830171 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27905330 |
| 86 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.27546614 |
| 87 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.23443536 |
| 88 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.21830149 |
| 89 | Proteasome_Homo sapiens_hsa03050 | 0.20603374 |
| 90 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.16351538 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.15755632 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.15196455 |
| 93 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.13831792 |
| 94 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.12257851 |
| 95 | HTLV-I infection_Homo sapiens_hsa05166 | 0.11558403 |
| 96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.10907544 |
| 97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.10649160 |
| 98 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.10524131 |
| 99 | Platelet activation_Homo sapiens_hsa04611 | 0.10284921 |
| 100 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.08051900 |

